Cite
HARVARD Citation
Zimmer, L. et al. (2015). Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma. Journal of translational medicine. 13 (1), pp. 1-11. [Online].